Apolipoprotein C-II is a novel substrate for matrix metalloproteinases
- 6 January 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 339 (1), 47-54
- https://doi.org/10.1016/j.bbrc.2005.10.182
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Matrix metalloproteinases in cancer: from new functions to improved inhibition strategiesThe International Journal of Developmental Biology, 2004
- NMR Structure of Human Apolipoprotein C-II in the Presence of Sodium Dodecyl SulfateBiochemistry, 2001
- Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatmentOncogene, 2000
- Matrix Metalloproteinases-3, -7, and -12, but Not -9, Reduce High Density Lipoprotein-induced Cholesterol Efflux from Human Macrophage Foam Cells by Truncation of the Carboxyl Terminus of Apolipoprotein A-IOnline Journal of Public Health Informatics, 1999
- Membrane Type 1 Matrix Metalloproteinase Expression in Human Atherosclerotic PlaquesCirculation, 1999
- Role of ApoCs in Lipoprotein MetabolismArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coliBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- PHOSPHOLIPID BINDING STUDIES WITH SYNTHETIC APOLIPOPROTEIN FRAGMENTS *Annals of the New York Academy of Sciences, 1980
- Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-IIThe New England Journal of Medicine, 1978
- A specific apoprotein activator for lipoprotein lipaseBiochemical and Biophysical Research Communications, 1970